Complete Up To Date Information about Palosein.
NADA Number: 045-863 | |
| Proprietary Name |
Palosein |
|---|---|
| Sponsor |
OXIS International, Inc. |
| Sponsor Address |
6040 N. Cutter Circle, Suite 317 Portland, OR 97217-3935 USA |
| Ingredients |
Orgotein |
| Species |
Horse, not for meat production Dog, no use class stated or implied |
| Routes of Administration |
Intramuscular Subcutaneous |
| Dose Form |
Liquid (solution) |
| Drug Form |
Liquid (solution) |
| Dispensing Status |
RX |
| Patent Number |
3637640 3637641 3758682 3773928 3773929 |
|
Dosage Amount, Indications & Limitations |
522.1620 Orgotein for injection. Specifications: Orgotein for injection is packaged in a vial containing 5 milligrams of orgotein and 10 milligrams of sucrose as lyophilized sterile non-pyogenic powder with directions for dissolving the contents of the vial in 2 milliliters of diluent which is sodium chloride injection, U.S.P. Conditions of use: Horses Amount: It is administered by deep intramuscular injection at a dosage level of 5 milligrams every other day for 2 weeks and twice weekly for 2 to 3 more weeks. Severe cases, both acute and chronic, may benefit more from daily therapy initially. Dosage may be continued beyond 5 weeks if satisfactory improvement has not been achieved. Indications: It is used in the treatment of soft tissue inflammation associated with the musculoskeletal system. Limitations: Not for use in horses intended for food. Dogs Amount: It is administered by subcutaneous injection at a dosage level of 5 milligrams every day for 6 days, and thereafter, every other day for 8 days. In less severe conditions shorter courses of therapy may be indicated. Indications; It is used for the relief of inflammation associated with ankylosing spondylitis, spondylosis, and disc disease. When severe nerve damage is present, response will occur much more slowly, if at all. Limitations: Federal law restricts this drug to use by or on the order of a licensed veterinarian. |